Supernus Pharmaceuticals
SUPN
#4268
Rank
A$3.02 B
Marketcap
$54.15
Share price
0.77%
Change (1 day)
6.33%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): $1.17

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $1.31. In 2022 the company made an earnings per share (EPS) of $1.87 an increase over its 2021 EPS that were of $1.69.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.17-37.51%
2022$1.8710.78%
2021$1.69-57.68%
2020$3.9912.09%
2019$3.560.47%
2018$3.5489.38%
2017$1.87-38.59%
2016$3.04534.48%
2015$0.48-211.54%
2014-$0.43-91.1%
2013-$4.8339.46%
2012-$3.46-69.27%
2011-$11.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$31.96 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.98 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.57 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.92 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.30 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA